Searching for chronic hepatitis B patients in a low prevalence area – role of racial origin
Open Access
- 13 April 2004
- journal article
- research article
- Published by Springer Nature in BMC Family Practice
- Vol. 5 (1) , 7
Abstract
Background Clinical studies for testing new drugs against hepatitis B ought to be carried out in low prevalence areas despite difficulties on patient recruitment. In such areas, relatives of chronic hepatitis B patients are considered to be at risk of acquiring the hepatitis B virus (HBV). The aim of this study was to evaluate the prevalence of HBV markers (anti-HBc, HBsAg and anti-HBs) in familial members of chronic hepatitis B (CHB) patients according to their origin (Asian or Western) in a low prevalence area, the city of São Paulo, Brazil. Methods Twenty three Asian CHB probands and their 313 relatives plus 31 CHB probands of Western origin and their 211 relatives were screened for HBV serological markers; the study was carried out in the outpatient clinic of the University of São Paulo School of Medicine. Results Mother to child transmission was greater in the Asian group whereas sexual transmission was more frequent in the Western group (p < 0.0001). Anti-HBc was positive in 90% and 57% of the Asian and Western parents (p = 0.0432) and in 97% and 33% of the Asian and Western brothers (p = 0.0001), respectively. HBsAg was more frequent among the Asian (66%) than the Western (15%) mothers (p = 0.0260) as well as among the Asian (81%) than the Western (19%) brothers (p = 0.0001). We could detect 110 new HBsAg-positive subjects related to the 54 index patients, being the majority (81%) of Asian origin. Conclusion In low prevalence area of hepatitis B, family members and household contacts of chronic HBV carriers are at high risk for acquiring hepatitis BKeywords
This publication has 13 references indexed in Scilit:
- Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudineTransplantation Proceedings, 2003
- Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymeraseGastroenterology, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis BNew England Journal of Medicine, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis BNew England Journal of Medicine, 2003
- Treatment of chronic hepatitis B: Case selection and duration of therapyJournal of Gastroenterology and Hepatology, 2002
- Management of hepatitis B: 2000—Summary of a workshopGastroenterology, 2001
- Current options for the therapy of chronic hepatitis B infectionCurrent Infectious Disease Reports, 2001
- Chronic hepatitis B in children: Natural history and treatmentJournal of Hepatology, 1993
- Postnatal Infectivity of Hepatitis B Surface Antigen-Carrier MothersThe Journal of Infectious Diseases, 1983
- Transmission of HBsAg from mother to infant in four ethnic groups.BMJ, 1978